Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Jul;52(609):433–437. doi: 10.1136/pgmj.52.609.433

The common hyperlipidaemias

Barry Lewis
PMCID: PMC2496403  PMID: 967762

Abstract

The treatment of primary hyperlipidaemic states is reviewed. While several metabolically distinct forms of hyperlipidaemia exist, it is possible to classify patients into three groups for the purpose of therapy.

Group 1 is defined as hypercholesterolaemia (due to raised levels of β-lipoprotein). In Group 2 the level of endogenous triglyceride is increased, with or without hypercholesterolaemia. In the rare Group 3, there is exogenous hypertriglyceridaemia. A satisfactory response can be attained in at least 90% of cases, using dietary and drug treatment.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  2. Carlson L. A., Ekelund L. G., Olsson A. G. Frequency of ischaemic exercise E.C.G. Changes in symptom-free men with various forms of primary hyperlipaemia. Lancet. 1975 Jul 5;2(7923):1–3. doi: 10.1016/s0140-6736(75)92948-7. [DOI] [PubMed] [Google Scholar]
  3. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Nikkilä E. A., Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973 May 5;1(7810):954–959. doi: 10.1016/s0140-6736(73)91598-5. [DOI] [PubMed] [Google Scholar]
  6. Onitiri A. C., Lewis B., Bentall H., Jamieson C., Wisheart J., Faris I. Lipoprotein concentrations in serum and in biopsy samples of arterial intima: a quantitive comparison. Atherosclerosis. 1976 May-Jun;23(3):513–519. doi: 10.1016/0021-9150(76)90011-3. [DOI] [PubMed] [Google Scholar]
  7. Patterson D., Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet. 1972 Feb 19;1(7747):393–399. doi: 10.1016/s0140-6736(72)90853-7. [DOI] [PubMed] [Google Scholar]
  8. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. doi: 10.1016/s0140-6736(69)90930-1. [DOI] [PubMed] [Google Scholar]
  9. Tabaqchali S., Chait A., Harrison R., Lewis B. Experience with simplified scheme of treatment of hyperlipidaemia. Br Med J. 1974 Aug 10;3(5927):377–380. doi: 10.1136/bmj.3.5927.377. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES